SecBot SecBot
SC 13G ·Filed Oct 22, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4d 2h ago SEC0001011712-26-000030
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any subsequent amendment converting this 13G to a 13D, which would signal activist intent. The 7.8% stake is below the typical threshold for immediate activism but large enough to be influential in a proxy contest or M&A scenario.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+1d
MMED ▲ +1.74% at T+1d
NEUTRAL call +1.74% · α vs SPY +1.03% · entry $18.34 → $18.66
Next anchor: T+5d in 3d
Entry = T+0 close
Oct 22, 2026
via day close
T+1d
+1.74%
call +1.74% · α +1.03%
$18.66
settled 3d ago
T+5d
Pending
in 3d
T+20d
Pending
in 24d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

Capital Ventures International, together with Susquehanna affiliates, disclosed a passive 7.8% stake in MiniMed Group via Schedule 13G, representing 21,911,680 shares as of October 15, 2026. The filing is routine for a passive investor with no intent to influence control, but the size of the stake (7.8%) signals meaningful conviction from a notable group of entities.

Key Financial Metrics

Stake
7.8%
Investor
Capital Ventures International

Key Facts

  • Capital Ventures International and four Susquehanna affiliates filed a joint Schedule 13G, disclosing aggregate beneficial ownership of 21,911,680 shares of MiniMed Group common stock.
  • The stake represents 7.8% of the 281,349,931 shares outstanding as of September 3, 2026 (per the company's Form 10-Q).
  • The filing is made under Rule 13d-1(c) — a passive investor statement with no intent to change or influence control of the issuer.
  • Susquehanna Securities, LLC holds options to buy 889,400 shares included in the total.
  • This is a new filing (not an amendment) dated October 22, 2026, with a beneficial ownership date of October 15, 2026.

Financial Impact

7.8% passive stake valued at approximately $21.9 million based on 21,911,680 shares (no per-share price provided in filing)

ownership_percentage

Risk Factors

  • Potential conversion to 13D if the group decides to engage actively with management.
  • Susquehanna entities may hedge or reduce the position, creating selling pressure.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001011712-26-000030
Document: mmed_sc13g-ex99.htm0001011712-26-000030
Document: 0001011712-26-000030-index-headers.html0001011712-26-000030
Document: 0001011712-26-000030-index.html0001011712-26-000030
Document: 0001011712-26-000030.txt0001011712-26-000030
22 reports for MMED
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MMED — sortable, filterable
TypeNow
Oct 22, 2026
4d ago
SC 13G
NEUTRAL ★ 4/10
$18.34awaiting T+20—$18.66 (+1.74%)
Oct 16, 2026
10d ago
SC 13G/A
NEUTRAL ★ 4/10
$17.79awaiting T+20—$18.66 (+4.89%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 6/10
$17.49awaiting T+20—$18.66 (+6.69%)
Oct 6, 2026
20d ago
EFFECT
NEUTRAL ★ 3/10
$19.64awaiting T+20—$18.66 (−4.99%)
Oct 1, 2026
24d ago
3
NEUTRAL ★ 2/10
$19.70awaiting T+20—$18.66 (−5.28%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
MIXED ★ 5/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 4/10
$21.97 $18.80▼ −14.43%▼ −16.69%$18.66 (−15.07%)
Showing 10 of 22

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 22, 2026